Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2011
06/30/2011US20110160215 Substituted Triazolo-Pyrazine Compounds
06/30/2011US20110160207 Heterocyclic amide compounds useful as kinase inhibitors
06/30/2011US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
06/30/2011US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments
06/30/2011US20110160164 Compounds for nonsense suppression and methods for their use
06/30/2011US20110160163 INHIBITORS OF p38
06/30/2011US20110160157 Methods of treating an inflammatory-related disease
06/30/2011US20110160136 Polyphenols for the treatment of cartilage disorders
06/30/2011US20110160135 Suppression of neuroendocrine diseases
06/30/2011US20110160129 Therapeutic Agent Preparations for Delivery Into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device
06/30/2011US20110160119 Anti-inflammatory compounds and uses thereof
06/30/2011US20110159131 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels
06/30/2011US20110159120 Synergistic anti-inflammatory compositions comprising boswellia serrata extracts
06/30/2011US20110159084 Raloxifene pharmaceutical formulations
06/30/2011US20110159071 Isolation and Identification of Glycosaminoglycans
06/30/2011US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them
06/30/2011US20110159068 Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support
06/30/2011US20110159057 Hydroxyapatite and bioglass-based pellets, production process and applications of thereof
06/30/2011US20110159053 Preparation of a cell concentrate from a physiological solution
06/30/2011US20110159011 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases
06/30/2011US20110159007 Stable and soluble antibodies inhibiting tnf alpha
06/30/2011US20110159005 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-hsd1) inhibitors and uses thereof
06/30/2011US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders
06/30/2011US20110158992 Engineered Anti-IL-23R Antibodies
06/30/2011US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
06/30/2011US20110158968 Methods of making enhanced, autologous fat grafts
06/30/2011US20110158966 Stem cells characterized by expression of germline specific genes
06/30/2011US20110158963 Three-dimensional matrices of structured porous monetite for tissue engineering and bone regeneration, and method of the preparation thereof
06/30/2011US20110158960 Isolation of precursor cells and their use for tissue repair
06/30/2011CA2786950A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
06/30/2011CA2785553A1 Treatment of osteoporosis
06/30/2011CA2785116A1 A combination for the treatment of osteoarthritis
06/30/2011CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor
06/30/2011CA2687713A1 Treatment of cancer, arthritis, inflammation and other diseases by drawing on skin the big dose of vitamin e in oil and covering by film
06/29/2011EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A)
06/29/2011EP2339002A1 Fibroblast growth factor homologs
06/29/2011EP2338976A1 Lactic acid bacterium having high oxalic acid decomposition ability
06/29/2011EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies
06/29/2011EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
06/29/2011EP2338887A1 Fused heterocyclic derivative and use thereof for medical purposes
06/29/2011EP2338886A2 Naphthalene derivatives
06/29/2011EP2338519A1 Agent for treating myelofibrosis
06/29/2011EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using
06/29/2011EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions
06/29/2011EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands
06/29/2011CN201881930U Automobile seat cushion
06/29/2011CN1812974B N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors
06/29/2011CN102112495A Dual variable domain immunoglobulins and uses thereof
06/29/2011CN102112494A Dual variable domain immunoglobulins and uses thereof
06/29/2011CN102108369A Application of DNA repair protein RAD51 in preparing medicament for treating osteosarcoma
06/29/2011CN102107001A Application of LXR nuclear receptor agonist in treatment and prevention of autoimmune diseases
06/29/2011CN102106988A Chinese medicine preparation with effects on expelling wind, dispelling cold and dampness, promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain
06/29/2011CN102106975A Traditional Chinese medicine preparation for treating lumbar disease
06/29/2011CN102106966A Preparation method of Chinese medicinal composition with functions of supplementing qi and nourishing blood
06/29/2011CN102106963A Ointment for treating acute gout attack and preparation method thereof
06/29/2011CN102106945A Swelling reliving and tendon and bone-knitting powder
06/29/2011CN102106938A Plant extract for treating gout and kidney disease and preparation method thereof
06/29/2011CN102106923A Chinese medicinal preparation for treating osteoporosis
06/29/2011CN102106921A Fumigating medicament for treating functional obstacle of injured joint
06/29/2011CN102106900A Formula of compound lamiophlomis-root dripping pill
06/29/2011CN102106896A New application of obscured homalomena rhizome (Chinese medicinal plant) in pharmacy
06/29/2011CN102106884A Medicinal composition having immunity-regulating function
06/29/2011CN102106838A Sulfasalazine enteric-coated preparation and preparation method thereof
06/29/2011CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies
06/29/2011CN102106831A 地西他滨冻干制剂及其制备方法 Decitabine lyophilized formulation and preparation method
06/29/2011CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology
06/29/2011CN102106801A Natural fatty acid ester peroxide decubitus prevention and treatment product and preparation method thereof
06/29/2011CN101862430B Chinese medicament for treating femoral head necrosis and preparation method thereof
06/29/2011CN101843789B Chinese medicament for treating gout
06/29/2011CN101797320B Medicine composition for preventing hyperosteogeny and preparation process thereof
06/29/2011CN101708265B Rheumatism curing powder
06/29/2011CN101700162B Nano-silver anti-bacterial anion far infrared multifunctional mattress (batts)
06/29/2011CN101647793B Application of anacardic acid in preparing anti-angiogenic drugs
06/29/2011CN101637555B Medicinal liquor soaked with snake
06/29/2011CN101618133B Application of yang-reinforcing kidney-protecting medicine in preparing medicine preventing and treating osteoporosis
06/29/2011CN101554398B Externally applied medical ointment for treating surgical infection and gout and preparation method thereof
06/29/2011CN101507736B Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism
06/29/2011CN101474268B Application of pharmaceutical composition in preparing medicament for treating bone fracture
06/29/2011CN101406590B Chinese medicinal composition for treating rheumatism osteonosus and preparation method
06/29/2011CN101406581B Ostalgia plaster
06/29/2011CN101390981B Bone fracture traditional Chinese medicine
06/29/2011CN101040949B Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and application
06/29/2011CN101001834B Nonpeptide inhibitors of matrix metalloproteinases
06/28/2011US7968716 Caspase inhibitors and uses thereof
06/28/2011US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid
06/28/2011US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby
06/28/2011US7968545 Compositions useful as inhibitors of voltage-gated ion channels
06/28/2011US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
06/28/2011US7968336 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
06/28/2011US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/28/2011CA2635196C Glucocorticoid receptor modulators
06/28/2011CA2494700C Calcium receptor modulating compound and use thereof
06/28/2011CA2494613C Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
06/28/2011CA2467672C Chemokine receptor antagonists and methods of use therefor
06/28/2011CA2460026C Porous ceramic composite bone grafts
06/23/2011WO2011075643A1 Substituted heteroaryl fused derivatives as pi3k inhibitors
06/23/2011WO2011075628A1 Heterocyclic compounds and their uses
06/23/2011WO2011074758A1 Process for preparing triglyceride oil containing high concentration of polyunsaturated fatty acids
06/23/2011WO2011073546A1 Injectable compositions for intra-articular use combining a viscosupplementation agent and a fibroblast growth medium
06/23/2011WO2011073277A1 PIPERIDINE ARYL SULFONAMIDE DERIVATIVES AS Kv1.3 MODULATORS